Joon Young Choi1, Hyoung Kyu Yoon2, Jae Ha Lee3, Kwang Ha Yoo4, Bo Yeon Kim5, Hye Won Bae5, Young Kyoon Kim1, Chin Kook Rhee1. 1. Division of Pulmonology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea. 2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. 3. Division of Pulmonology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea. 4. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, South Korea. 5. Health Insurance Review & Assessment Service, Wonju, South Korea.
Abstract
BACKGROUND: Quality control is important for patients with asthma because of its prevalence and because the social burden is substantial. This study analyzed the Health Insurance Review and Assessment Service (HIRA) database to assess asthma quality control in South Korea. METHODS: We investigated the HIRA nationwide database for reimbursed insurance claims from all medical institutions in South Korea from July 2013 to June 2014. The number of patients with asthma were evaluated and the medical institutions were categorized by type of medical institution. Asthma care quality was assessed by measuring the performance rate on pulmonary function test (PFT) and investigating prescriptions for asthma medications. RESULTS: A total of 16,804 medical institutions and 831,613 patients were included in this study. Among them, primary health clinics accounted for 87.75% of all medical institutions and 82.50% of patients were treated in a primary health clinic. The overall PFT performance rate was 23.47%, which was highest in tertiary hospitals (80.59%) and relatively lower in primary health clinics (17.06%). Oral agents were prescribed to 93.96% of patients, whereas inhaled agents were prescribed to only 30.34%. Oral corticosteroids were prescribed to 40.61% of patients, leukotriene antagonists to 48.78%, and inhaled corticosteroids (ICS) to 25.37% of patients by drug category. CONCLUSIONS: Most patients with asthma were treated in primary health clinics rather than higher class medical institutions. Asthma quality control was poor regarding usage of diagnostic measures and prescribed medications.
BACKGROUND: Quality control is important for patients with asthma because of its prevalence and because the social burden is substantial. This study analyzed the Health Insurance Review and Assessment Service (HIRA) database to assess asthma quality control in South Korea. METHODS: We investigated the HIRA nationwide database for reimbursed insurance claims from all medical institutions in South Korea from July 2013 to June 2014. The number of patients with asthma were evaluated and the medical institutions were categorized by type of medical institution. Asthma care quality was assessed by measuring the performance rate on pulmonary function test (PFT) and investigating prescriptions for asthma medications. RESULTS: A total of 16,804 medical institutions and 831,613 patients were included in this study. Among them, primary health clinics accounted for 87.75% of all medical institutions and 82.50% of patients were treated in a primary health clinic. The overall PFT performance rate was 23.47%, which was highest in tertiary hospitals (80.59%) and relatively lower in primary health clinics (17.06%). Oral agents were prescribed to 93.96% of patients, whereas inhaled agents were prescribed to only 30.34%. Oral corticosteroids were prescribed to 40.61% of patients, leukotriene antagonists to 48.78%, and inhaled corticosteroids (ICS) to 25.37% of patients by drug category. CONCLUSIONS: Most patients with asthma were treated in primary health clinics rather than higher class medical institutions. Asthma quality control was poor regarding usage of diagnostic measures and prescribed medications.
Entities:
Keywords:
Asthma; Korea; nationwide population-based; primary care; quality control
Authors: Patrick W Sullivan; Vahram H Ghushchyan; Julia F Slejko; Vasily Belozeroff; Denise R Globe; Shao-Lee Lin Journal: J Allergy Clin Immunol Date: 2011-02 Impact factor: 10.793
Authors: Patrick W Sullivan; Julia F Slejko; Vahram H Ghushchyan; Brandon Sucher; Denise R Globe; Shao-Lee Lin; Gary Globe Journal: J Asthma Date: 2014-04-07 Impact factor: 2.515
Authors: Anne L Fuhlbrigge; Robert J Adams; Theresa W Guilbert; Evie Grant; Paula Lozano; Susan L Janson; Fernando Martinez; Kevin B Weiss; Scott T Weiss Journal: Am J Respir Crit Care Med Date: 2002-10-15 Impact factor: 21.405
Authors: Christopher K W Lai; Teresita S De Guia; You-Young Kim; Sow-Hsong Kuo; Amartya Mukhopadhyay; Joan B Soriano; Pham Long Trung; Nan Shan Zhong; Norzila Zainudin; B M Z Zainudin Journal: J Allergy Clin Immunol Date: 2003-02 Impact factor: 10.793
Authors: Min Hye Kim; Chin Kook Rhee; Ji Su Shim; So Young Park; Kwang Ha Yoo; Bo Yeon Kim; Hye Won Bae; Yun Su Sim; Jung Hyun Chang; Young Joo Cho; Jin Hwa Lee Journal: Allergy Asthma Immunol Res Date: 2019-11 Impact factor: 5.764
Authors: Eugene R Bleecker; Andrew N Menzies-Gow; David B Price; Arnaud Bourdin; Stephen Sweet; Amber L Martin; Marianna Alacqua; Trung N Tran Journal: Am J Respir Crit Care Med Date: 2020-02-01 Impact factor: 21.405